Cargando…
Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders
Depression and cognitive disorders are diseases with complex and not-fully understood etiology. Unfortunately, the COVID-19 pandemic dramatically increased the prevalence of both conditions. Since the current treatments are inadequate in many patients, there is a constant need for discovering new co...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559442/ https://www.ncbi.nlm.nih.gov/pubmed/34736882 http://dx.doi.org/10.1016/j.neubiorev.2021.10.037 |